Control Plasma N, Proc Control Plasma
Plasma, Coagulation Control. 510(k) K042333, from Dade Behring, Inc. (Newark, DE). Product code GGN, class 2.
As of Nov 19, 2026, K042333 is an FDA 510(k) held by Dade Behring, Inc., substantially equivalent on Dec 1, 2004 after 93 days, with no recalls tied to it in FDA's recall database.
- Review time: 93 days
- Recalls: 0
Control Plasma N is an assayed control for use in monitoring performance of the following parameters in the normal range: 1. Prothrombin time (PT) 2. Activated partial thromboplastin time (APTT) 3. Thrombin time (TT) 4. Batroxobin time 5. Fibrinogen 6. Coagulation factors II, V, VII, VIII, vWF, IX, X, XI, XII 7. Inhibitors: Antithrombin III, protein C, protein S, \alpha2 –antiplasmin 8.
- Control Plasma NK023309 · Dade Behring, Inc. · Nov 1, 2002
- Coatest Apc (Tm) Resistance V/Coatest Apc (Tm) Resistance V SK963111 · Chromogenix AB · Dec 23, 1996
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 30, 2004
- Review panel
- Hematology
- Regulation
- 21 CFR 864.5425
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files